# Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia

> **NCT03734562** · NA · COMPLETED · sponsor: **Hospital General Universitario Gregorio Marañon** · enrollment: 180 (actual)

## Conditions studied

- Monomorphic Ventricular Tachycardia

## Interventions

- **PROCEDURE:** Ablation
- **DRUG:** Antiarrhythmic drug

## Key facts

- **NCT ID:** NCT03734562
- **Lead sponsor:** Hospital General Universitario Gregorio Marañon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2017-09-29
- **Final completion:** 2017-09-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734562, "Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03734562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*